Researchers at UCLA have found a way to supercharge immune cells with a fuel source that tumors can't steal, dramatically ...

UT Southwestern Medical Center researchers have identified two lipids that work together with a quintessential protein known ...

Adults with differentiated thyroid cancer who are using a GLP-1 for the treatment of diabetes or obesity do not have increased risk for cancer recurrence or progression vs. those not using a GLP-1, ...

Scientists have made a breakthrough that could lead to effective treatments for lymphedema, a painful swelling condition for ...

A new discovery involving the larva of zebrafish shows promise for treating or preventing painful lymphoedema.

Colorectal cancer is now the leading cause of cancer deaths among people younger than 50 in the United States, according to a study published Thursday in the Journal of the American Medical ...

Add Yahoo as a preferred source to see more of our stories on Google. A new study from the American Cancer Society is shedding light on cancer mortality rates among young people — and the one type of ...

Glucagon-like peptide-1 receptor agonist therapy with liraglutide or semaglutide is not associated with an increased risk for thyroid cancer among patients with type 2 diabetes or obesity, according ...

As more continues to be understood about the health benefits associated with GLP-1 drugs, a growing body of science is aiming to answer whether the popular weight-loss medication can help with one of ...

The iShares Global Infrastructure ETF offers diversified exposure across utilities, transportation, and energy infrastructure, emphasizing predictability and defense. IGF's current valuations reflect ...

OKLAHOMA CITY – The success of GLP-1 medications for treating Type 2 diabetes and obesity naturally leads to a related question: Do GLP-1 drugs affect cancer risk, which is often associated with ...